Maryland State Retirement & Pension System Has $411,000 Stock Holdings in Azenta, Inc. $AZTA

Maryland State Retirement & Pension System decreased its stake in shares of Azenta, Inc. (NASDAQ:AZTA) by 14.4% in the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 13,346 shares of the company’s stock after selling 2,247 shares during the period. Maryland State Retirement & Pension System’s holdings in Azenta were worth $411,000 at the end of the most recent quarter.

A number of other hedge funds have also added to or reduced their stakes in the business. Mechanics Financial Corp grew its position in Azenta by 77.6% in the second quarter. Mechanics Financial Corp now owns 870 shares of the company’s stock valued at $27,000 after purchasing an additional 380 shares in the last quarter. State of Alaska Department of Revenue lifted its stake in shares of Azenta by 7.6% during the 2nd quarter. State of Alaska Department of Revenue now owns 27,238 shares of the company’s stock worth $838,000 after buying an additional 1,918 shares during the last quarter. Counterpoint Mutual Funds LLC acquired a new stake in shares of Azenta during the 2nd quarter worth about $343,000. GAMMA Investing LLC lifted its stake in shares of Azenta by 83.6% during the 2nd quarter. GAMMA Investing LLC now owns 3,446 shares of the company’s stock worth $106,000 after buying an additional 1,569 shares during the last quarter. Finally, Farther Finance Advisors LLC lifted its stake in shares of Azenta by 41.6% during the 2nd quarter. Farther Finance Advisors LLC now owns 1,371 shares of the company’s stock worth $42,000 after buying an additional 403 shares during the last quarter. Institutional investors own 99.08% of the company’s stock.

Analyst Upgrades and Downgrades

Several research firms have commented on AZTA. Raymond James Financial raised shares of Azenta from a “market perform” rating to an “outperform” rating and set a $35.00 target price on the stock in a report on Wednesday, August 6th. Evercore ISI set a $33.00 target price on shares of Azenta and gave the stock an “in-line” rating in a research note on Tuesday, August 5th. Stephens started coverage on shares of Azenta in a research note on Tuesday, July 22nd. They set an “equal weight” rating and a $35.00 target price on the stock. Finally, Weiss Ratings reissued a “sell (d-)” rating on shares of Azenta in a report on Wednesday, October 8th. Two research analysts have rated the stock with a Buy rating, three have issued a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat.com, Azenta presently has a consensus rating of “Hold” and an average target price of $35.75.

Azenta Stock Up 2.4%

Azenta stock opened at $30.52 on Tuesday. Azenta, Inc. has a 12-month low of $23.91 and a 12-month high of $55.63. The firm’s fifty day moving average is $30.15 and its 200 day moving average is $29.68. The company has a market capitalization of $1.40 billion, a PE ratio of -12.61 and a beta of 1.62.

Azenta (NASDAQ:AZTA) last released its earnings results on Tuesday, August 5th. The company reported $0.19 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.13 by $0.06. Azenta had a negative net margin of 18.45% and a positive return on equity of 1.35%. The company had revenue of $143.94 million for the quarter, compared to the consensus estimate of $149.64 million. During the same quarter in the previous year, the company earned $0.14 EPS. Azenta’s quarterly revenue was up .0% compared to the same quarter last year. Sell-side analysts expect that Azenta, Inc. will post 0.53 EPS for the current fiscal year.

Azenta Profile

Azenta, Inc provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.